Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00639223 · ClinicalTrials.gov registry record · Phase 2
Safety of Red Yeast Rice for High Cholesterol in Individuals With Statin Intolerance
A Phase 2 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 43
- Enrollment target
NCT00639223: Completed Phase 2 study, sponsored by University of Pennsylvania.
NCT00639223 is a Phase 2 study that has completed, run by University of Pennsylvania. The registered enrollment target is 43 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00639223, a Phase 2 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 43 participants
- Enrollment target
Study Summary
This study will examine the effect of red yeast rice extract compared to pravastatin on muscle related complaints in individuals with high cholesterol who have previously been unable to tolerate statin medications due to muscle pain. The study will determine whether red yeast is associated with a lower level of muscle related complaints compared to pravastatin.
Interventions
- DRUG Pravastatin
- DIETARY_SUPPLEMENT Red Yeast Rice
- BEHAVIORAL Lifestyle modification program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-10 |
| Phase | Phase 2 |
What the finished NCT00639223 record still lists
NCT00639223 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 3 interventions - of which Pravastatin is the first listed.
NCT00639223 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00639223 about?
NCT00639223 is a clinical study titled "Safety of Red Yeast Rice for High Cholesterol in Individuals With Statin Intolerance". This study will examine the effect of red yeast rice extract compared to pravastatin on muscle related complaints in individuals with high cholesterol who have previously been unable to tolerate statin medications due to muscle pain. The study will determine whether red yeast is associated with a lo...
What is the current status of trial NCT00639223?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 43 participants. The study started on 2008-01. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00639223?
The interventions under investigation include: Pravastatin (DRUG), Red Yeast Rice (DIETARY_SUPPLEMENT), Lifestyle modification program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00639223?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00639223's enrollment target sits among peer trials
43 1332nd of 2000 higher than 662 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia